Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and bone density changes in rheumatoid arthritis
2010-020499-50Phase 4Completed
- Sponsor
- South Tees Hospitals NHS Foundation Trust
- Start
- Dec 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by South Tees Hospitals NHS Foundation Trust. Primary endpoint: Change in bone mineral density of spine. Started Dec 2010; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-020499-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020499-50.